CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Optical coherence tomography and intravascular ultrasound assessment of the anatomic size and wall thickness of a muscle bridge segment Dilated cardiomyopathy: so many cardiomyopathies! The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling The Objective Physical Activity and Cardiovascular Disease Health in Older Women (OPACH) Study Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Circadian-Regulated Cell Death in Cardiovascular Diseases

Editorial2017 Dec 12;70(23):2875-2877.

JOURNAL:J Am Coll Cardiol. Article Link

Can the Vanishing Stent Reappear? Fix the Technique, or Fix the Device?

King SB 3rd, Gogas BD. Keywords: bioresorbable vascular scaffold; prognosis; randomized trial; stent; technique; thrombosis

FULL TEXT PDF